Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue

Molecular Imaging Clinical Trial

Official title:
Evaluation of the Effect of Fasting and Exercise on Uptake of Tc-99m Sestamibi in Breast Tissue

Status Completed

Clinical Trial Summary

The primary objective of this study is to determine if exercise, fasting, or eating prior to the molecular breast imaging study will have an effect on the uptake of the tracer in the breast tissue.

Clinical Trial Description

The primary objective of this study is to determine if exercise, fasting, or eating prior to a molecular breast imaging study will have an effect on the uptake of the radiotracer Tc-99m sestamibi in the breast tissue.

Tc-99m sestamibi is primarily extracted by the liver. Changes in hepatic blood flow may therefore influence the amount of radiotracer available for uptake in the breast tissue. ;

Study Design

Related Conditions & MeSH terms

Molecular Imaging

Clinical Trial Details

NCT number	NCT01944215
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	Phase 1
Start date	September 2013
Completion date	April 2015

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02916329` - In Vivo EGFR-ECD Molecular Imaging Using [68Ga]- Labelling Anti-EGFR Affibody Molecule	N/A
Recruiting	`NCT02916394` - In Vivo IGF-1R Molecular Imaging Using [68Ga]- Labelling Anti-IGF-1R Affibody Molecule	N/A
Active, not recruiting	`NCT03358589` - Molecular Evaluation in Metastatic Breast Cancer	N/A
Completed	`NCT03031522` - EGFR Molecular Classification In Vivo	N/A
Recruiting	`NCT02717221` - In Vivo EGFR Molecular Classification and Treatment Response	N/A
Completed	`NCT03233243` - Rosuvastatin Effect on Atherosclerotic Plaque Metabolism	Phase 4
Completed	`NCT02323217` - I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers	Early Phase 1
Enrolling by invitation	`NCT05575765` - Clinical Validation of Multimodal Digestive Endoscopy